|
AGAP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.429200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.419230E-01 |
| Normal-vs-Stage2 |
3.843000E-01 |
| Normal-vs-Stage3 |
5.544800E-01 |
| Normal-vs-Stage4 |
8.695200E-01 |
| Stage1-vs-Stage2 |
9.650600E-01 |
| Stage1-vs-Stage3 |
2.038500E-02 |
| Stage1-vs-Stage4 |
2.605800E-01 |
| Stage2-vs-Stage3 |
1.867200E-01 |
| Stage2-vs-Stage4 |
4.781400E-01 |
| Stage3-vs-Stage4 |
4.682000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.372800E-01 |
| Normal-vs-AfricanAmerican |
1.368390E-01 |
| Normal-vs-Asian |
8.191400E-01 |
| Caucasian-vs-AfricanAmerican |
1.251780E-01 |
| Caucasian-vs-Asian |
9.081200E-01 |
| AfricanAmerican-vs-Asian |
1.584240E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.996800E-01 |
| Normal-vs-Female |
2.170800E-01 |
| Male-vs-Female |
1.614570E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.595600E-02 |
| Normal-vs-Age(41-60Yrs) |
9.897000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.770800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.602400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.126100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.957600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.561600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.634800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.303200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.136800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.024900E-04 |
| Classical-VS-Follicular |
3.743000E-01 |
| Classical-VS-Other |
7.080500E-02 |
| Classical-VS-Normal |
8.523900E-02 |
| Tall-VS-Follicular |
7.326200E-02 |
| Tall-VS-Other |
3.217600E-01 |
| Tall-VS-Normal |
1.329030E-01 |
| Follicular-VS-Other |
4.650400E-02 |
| Follicular-VS-Normal |
6.602600E-01 |
| Other-VS-Normal |
9.030400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.345600E-01 |
| Normal-vs-N1 |
7.707400E-01 |
| N0-vs-N1 |
9.275800E-01 |
|
|
